Table 1.
Patient characteristics
| SPECT/CT positive (n = 13) | SPECT/CT negative (n = 7) | Total (n = 20) | |
|---|---|---|---|
| Age, years, mean ± SD | 53·3 ± 8·4 | 48·6 ± 9·6 | 51·7 ± 8·9 |
| Sex, male (%) | 11 (85) | 7 (100) | 18 (90) |
| Diabetes, type II (%) | 11 (85) | 7 (100) | 18 (90) |
| Tobacco use | |||
| Current (%) | 5 (39) | 1 (14) | 6 (30) |
| Past (%) | 2 (15) | 1 (14) | 3 (15) |
| Never (%) | 6 (46) | 5 (72) | 11 (55) |
| Comorbidities | |||
| PAD (%) | 6 (46) | 2 (29) | 8 (40) |
| CKD (%) | 7 (54) | 2 (29) | 9 (45) |
| CAD (%) | 3 (23) | 0 (0) | 3 (15) |
| Hep (%) | 1 (8) | 0 (0) | 1 (5) |
| Type of therapy | |||
| IV (%) | 1 (8) | 1 (14) | 2 (10) |
| Oral (%) | 1 (8) | 0 (0) | 1 (5) |
| IV and oral (%) | 4 (30) | 3 (43) | 7 (37) |
| IV, oral and PFA (%) | 7 (54) | 2 (29) | 9 (48) |
| Duration of antibiotic therapy (weeks) | 19·2 ± 12·5 | 11·5 ± 4·7 | 16·5 ± 10·9 (range 4–36) |
CAD, coronary artery disease; CKD, chronic kidney disease; Hep, hepatitis; IV, intravenous antibiotics; Oral, oral antibiotics; PAD, peripheral artery disease; PFA, partial foot amputation; SD, standard deviation.